Philippe  Menu net worth and biography

Philippe Menu Biography and Net Worth

Insider of SOPHiA GENETICS

Philippe Menu, M.D., Ph.D., M.B.A., brings a unique blend of medical expertise across clinical medicine, fundamental research in molecular biology, and business management consulting. He joined SOPHiA GENETICS in February 2020 as Chief Medical Officer, and in March 2023 was appointed Chief Product Officer and Chief Medical Officer.

Prior to joining SOPHiA GENETICS, Philippe spent 8 years at McKinsey & Company serving dozens of clients in the BioPharma sector. He advised global pharmaceutical companies, mid-size players, and biotechs alike across the pharma value chain with a major focus on innovative therapies and diagnostics in oncology and rare diseases.
 
Prior to that, Philippe was a post-doctoral fellow at the University of Lausanne.

Philippe holds an M.D. and a Ph.D. from the University of Lausanne, and an M.B.A. in life sciences from the Open University Business School.

What is Philippe Menu's net worth?

The estimated net worth of Philippe Menu is at least $1.39 million as of April 27th, 2026. Dr. Menu owns 261,388 shares of SOPHiA GENETICS stock worth more than $1,392,675 as of May 1st. This net worth approximation does not reflect any other assets that Dr. Menu may own. Learn More about Philippe Menu's net worth.

How do I contact Philippe Menu?

The corporate mailing address for Dr. Menu and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Philippe Menu's contact information.

Has Philippe Menu been buying or selling shares of SOPHiA GENETICS?

During the last quarter, Philippe Menu has sold $121,062.54 in shares of SOPHiA GENETICS stock. Most recently, Philippe Menu sold 5,000 shares of the business's stock in a transaction on Monday, April 27th. The shares were sold at an average price of $4.82, for a transaction totalling $24,100.00. Following the completion of the sale, the insider now directly owns 261,388 shares of the company's stock, valued at $1,259,890.16. Learn More on Philippe Menu's trading history.

Who are SOPHiA GENETICS's active insiders?

SOPHiA GENETICS's insider roster includes Philippe Menu (Insider), and Kevin Puylaert (SVP, Chief Sales Officer). Learn More on SOPHiA GENETICS's active insiders.

Are insiders buying or selling shares of SOPHiA GENETICS?

In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.

Information on this page was last updated on 4/27/2026.

Philippe Menu Insider Trading History at SOPHiA GENETICS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/27/2026Sell5,000$4.82$24,100.00261,388View SEC Filing Icon  
4/20/2026Sell608$5.20$3,161.60266,388View SEC Filing Icon  
4/14/2026Sell1,600$4.96$7,936.00266,996View SEC Filing Icon  
4/13/2026Sell4,400$4.76$20,944.00268,596View SEC Filing Icon  
4/10/2026Sell3,725$4.68$17,433.00272,996View SEC Filing Icon  
4/9/2026Sell1,931$4.74$9,152.94276,721View SEC Filing Icon  
4/8/2026Sell2,800$4.84$13,552.00278,652View SEC Filing Icon  
4/7/2026Sell2,400$4.87$11,688.00281,452View SEC Filing Icon  
4/6/2026Sell2,700$4.85$13,095.00283,852View SEC Filing Icon  
3/19/2026Sell608$4.79$2,912.32173,616View SEC Filing Icon  
See Full Table

Philippe Menu Buying and Selling Activity at SOPHiA GENETICS

This chart shows Philippe Menu's buying and selling at SOPHiA GENETICS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SOPHiA GENETICS Company Overview

SOPHiA GENETICS logo
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Read More

Today's Range

Now: $5.32
Low: $5.23
High: $5.37

50 Day Range

MA: $4.81
Low: $4.10
High: $5.28

2 Week Range

Now: $5.32
Low: $2.59
High: $5.70

Volume

51,479 shs

Average Volume

169,220 shs

Market Capitalization

$364.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04